Answer
No specific nonclinical fertility study has been conducted with ravulizumab, but reproductive toxicology studies in mice using the murine surrogate molecule BB5.1 identified no adverse effect on fertility in treated females or males.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked